Please login to the form below

personalised medicine

This page shows the latest personalised medicine news and features for those working in and with pharma, biotech and healthcare.

AZ and CRUK launch Cambridge genomics centre

As we move into an era of personalised medicine, we’ve reached a turning point in our ability to harness powerful technologies in the pursuit of targeted cancer therapies.

Latest news

Genomics England reaches 100,000th genome sequencing milestone

The company worked collaboratively with the NHS to launch NHS Genomic Medicine Centres (GMCs), which recruited participants for the project. ... If all goes well, the UK could be a world leader in personalised medicine, which would help make the country
Hancock says UK genome service is now ‘rolling out’

In his speech at the Conservative Party Conference in Birmingham yesterday, Hancock said the project had met its goal of helping to create a new genomic medicine service for the NHS, ... The news was welcomed by Mike Thompson, chief executive of the
Call for genetic tests to bring personalised medicine to children with cancer

NHS England plans to introduce an NHS Genomic Medicine Service shortly to begin putting in place the resources and infrastructure to expand access to sequencing. ... They say new funding and changes in clinical practice can turn the promise of the NHS
UK pharma to work with innovation network on NHS uptake

The five year deal covers AI, genomics, personalised medicine and more. ... These areas include economic growth, digital and artificial intelligence, research, genomics and personalised medicine, diagnostics and medicines optimisation.
The Directory and digital round-up

Kyomed re-brands and launches new app. Kyomed, a French company offering services in connected healthcare, autonomy and personalised medicine, marks its fourth anniversary, rebranding to KYomed INNOV. ... The new app is powered by artificial intelligence

More from news
Approximately 10 fully matching, plus 97 partially matching documents found.

Latest Intelligence

Cancer in The Information Age: are we illuminated or inundated?

Personalised vs personal medicine. Data and information have already proved fruitful in the clinic, yielding the advent of personalised cancer medicine,. ... But for all the promise of personalised medicine, it can limit perspective, drawing clinical
The challenges of making genomics a reality for patients

It ushered in a new era of what we now call personalised medicine. ... To put this in context, developing the first cystic fibrosis medicine that treats the underlying cause took.
Bridging pharma’s digital gap

The rise of sophisticated technology assisting in the creation of personalised medicine would be naming just one example that came as a great leap for both the industry and mainstream medicine. ... The desire for customers to have personalised content
The challenges of making genomics a reality for patients today, not tomorrow

It ushered in a new era of what we now call personalised medicine. ... We hope this means 90% of cystic fibrosis patients will one day be eligible for medicine able to treat the underlying cause of the disease.
The real-world data conundrum

How data is changing the healthcare industries. No matter how we look at it, our approaches towards medicine are changing. ... At the core of this spectrum are patients. As the understanding of stratified, personalised medicine has grown over the last

More from intelligence
Approximately 4 fully matching, plus 24 partially matching documents found.

Latest appointments

BMS appoints new commercial leader, Davies joins Eisai and more

The field of genomic medicine has the potential to revolutionise our approach to rare genetic disease diagnosis and management, as well as in other areas of personalised medicine.”.
Stephen Eck joins Aravive Biologics

chairman of the board of directors of the Personalised Medicine Coalition.
FlowMetric Diagnostics names president

It is a great time for the development of new flow cytometry-based companion diagnostics which can help advance personalised medicine and better meet the needs of physicians, healthcare workers and
GlobalData makes Americas appointment

Dr Bonnie Bain, global head of healthcare at GlobalData, adds: “Sean is widely recognised as an expert and thought leader in personalised and translational medicine, and it's great to welcome
Roche appoints new oncology research head

Personalised cancer has been his forte, however, and he has served as director of personalised cancer medicine at Vanderbilt. ... I was particularly attracted to Roche as one of the pioneers and front-runners in personalised medicine, as the world's top

More from appointments
Approximately 0 fully matching, plus 8 partially matching documents found.

Latest from PMHub

Highlights in haematologic malignancy from ASH 2018

Here we focus on two areas of personalised medicine from the oncology setting. ... The team is working to further enhance the new model, which may offer a more personalised tool for assessing risk and informing treatment choice (e.g.
3MZ Healthcare Communications: Improving Human Care

healthcare, personalised medicine and digital health.
Mastering the precision medicine opportunity

When I was studying and working in labs, personalised medicine drew me in as a new methodology and innovative way to treat patients. ... In personalised medicine, we ask if we can use a particular treatment in a patient.
Training the next generation of biotech leaders

therapy. As the focus shifts to the development of personalised medicine, further innovation in the manufacturing process and equipment is needed. ... With the advent of personalised medicine, biotechs and academia are focusing their efforts on ensuring
Communication shouldn’t be a case of forcing a square peg into a round hole

Communicating effectively: still a work in progress. As the Evidence &Information Manager at Hayward, I’m a great believer that communication should be informative and framed within a pragmatic approach that elicits change rather than merely